In fiscal year 2019 , the Japanese pharmaceutical company Takeda Pharmaceutical Co. , Ltd generated a revenue of approximately 3.29 trillion Japanese yen , up from around 2.1 trillion yen in the previous fiscal year . The company mainly focuses on the therapeutic areas oncology , gastroenterology and neuroscience .
